The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-((3-Acetylphenyl)(2-hydroxyethyl)amino)-4'-methyl-[4,5'-bithiazol]-2'-yl)acetamide ID: ALA4531023
PubChem CID: 155546020
Max Phase: Preclinical
Molecular Formula: C19H20N4O3S2
Molecular Weight: 416.53
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)Nc1nc(C)c(-c2csc(N(CCO)c3cccc(C(C)=O)c3)n2)s1
Standard InChI: InChI=1S/C19H20N4O3S2/c1-11-17(28-18(20-11)21-13(3)26)16-10-27-19(22-16)23(7-8-24)15-6-4-5-14(9-15)12(2)25/h4-6,9-10,24H,7-8H2,1-3H3,(H,20,21,26)
Standard InChI Key: ZAAVGWLFVJKADF-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
19.9457 -16.0409 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.2844 -15.5600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5343 -14.7821 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.3529 -14.7821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6069 -15.5600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3981 -15.7719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0342 -15.2550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7175 -15.7018 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.5057 -16.4925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6891 -16.5372 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.0851 -17.0719 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.8763 -16.8600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0886 -16.0687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8767 -15.8588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4563 -16.4384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2440 -17.2246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4551 -17.4388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0886 -15.0675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5093 -14.4882 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.8799 -14.8556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8732 -17.8590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4525 -18.4384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2406 -19.2296 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.7643 -14.0747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4932 -15.7719 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9138 -15.1926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1226 -15.4045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1257 -14.4013 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
6 5 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
9 11 1 0
11 12 1 0
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
12 17 1 0
14 18 1 0
18 19 2 0
18 20 1 0
11 21 1 0
21 22 1 0
22 23 1 0
4 24 1 0
2 25 1 0
25 26 1 0
26 27 1 0
26 28 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 416.53Molecular Weight (Monoisotopic): 416.0977AlogP: 3.87#Rotatable Bonds: 7Polar Surface Area: 95.42Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.98CX Basic pKa: 0.43CX LogP: 2.59CX LogD: 2.49Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.57Np Likeness Score: -1.70
References 1. Tassini S, Langron E, Delang L, Mirabelli C, Lanko K, Crespan E, Kissova M, Tagliavini G, Fontò G, Bertoni S, Palese S, Giorgio C, Ravanetti F, Ragionieri L, Zamperini C, Mancini A, Dreassi E, Maga G, Vergani P, Neyts J, Radi M.. (2019) Multitarget CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach †., 62 (23): [PMID:31729878 ] [10.1021/acs.jmedchem.9b01416 ]